For adenocarcinoma, particularly intestinal type, an immunopanel including CK7, CK20, CDX2, and SATB2 (± PAX8) should be interpreted alongside a directed GI work-up to exclude metastasis. Here, CDX2 is linked to adenocarcinoma.